Antimicrobial Peptide (AMP) Discovery epsilon=0.0
3,414.2Unique Predicted-Resistant PeptidesB3-TR
Evaluation results
| Method | Links | |
|---|---|---|
| B3-TRModel=Boosted GFlowNet, Number of models=3, Objective variant=Target-Residual (TR), Alpha=0.02025.11 | 3,414.2 | |
| B2-TRModel=Boosted GFlowNet, Number of models=2, Objective variant=Target-Residual (TR), Alpha=0.02025.11 | 2,672 | |
| B3-FAModel=Boosted GFlowNet, Number of models=3, Objective variant=Flow-Additive (FA), Alpha=1.02025.11 | 45.2 | |
| B2-FAModel=Boosted GFlowNet, Number of models=2, Objective variant=Flow-Additive (FA), Alpha=1.02025.11 | 41 | |
| SGModel=Single GFlowNet, Number of models=12025.11 | 32.6 |